• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Hans-Olov Adami, MD, PhD


  • Ghiasvand R, Adami HO, Harirchi I, Akrami R, Zendehdel K.Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?.BMC Cancer. 2014;14(1):343.
  • Holmes MD, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson TM, Adami HO, Askling J, Smedby KE.Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden.BMC Cancer. 2014 Jun 2;14(1):391.
  • Adami HO, Bill-Axelson A, Johansson JE.Management of early prostate cancer.N Engl J Med. 2014 May 29;370(22):2151.
  • Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K, Patel AV, Adami HO, Weiderpass E, Giles GG, Singh PN, Alavanja M, Beane Freeman LE, Bernstein L, Buring JE, Colditz GA, Fraser GE, Gapstur SM, Michael Gaziano J, Giovannucci E, Hofmann JN, Linet MS, Neta G, Park Y, Purdue MP.Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.British Journal of Haematology. 2014 May 23.
  • Preston MA, Riis AH, Ehrenstein V, Breau RH, Batista JL, Olumi AF, Mucci LA, Adami HO, Sørensen HT.Metformin Use and Prostate Cancer Risk.Eur Urol. 2014 May 21.
  • Chang ET, Adami HO, Boffetta P, Cole P, Starr TB, Mandel JS.A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans.Crit. Rev. Toxicol. 2014 Jun;44 Suppl 1:1-81.
  • Hjelmborg JB, Scheike T, Holst K, Skytthe A, Penney KL, Graff RE, Pukkala E, Christensen K, Adami HO, Holm NV, Nuttall E, Hansen S, Hartman M, Czene K, Harris JR, Kaprio J, Mucci LA.The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer.Cancer Epidemiol Biomarkers Prev. 2014 May 8.
  • Chang ET, Adami HO, Bailey WH, Boffetta P, Krieger RI, Moolgavkar SH, Mandel JS.Validity of geographically modeled environmental exposure estimates.Crit. Rev. Toxicol. 2014 May;44(5):450-66.
  • Wickberg A, Holmberg L, Adami HO, Magnuson A, Villman K, Liljegren G.Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial.J Clin Oncol. 2014 Mar 10;32(8):791-7.
  • Iliadou AN, Petridou E, Adami HO.Cancer risk among children born after assisted conception.N Engl J Med. 2014 Mar 6;370(10):974.
  • Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Spångberg A, Andrén O, Palmgren J, Steineck G, Adami HO, Johansson JE.Radical prostatectomy or watchful waiting in early prostate cancer.N Engl J Med. 2014 Mar 6;370(10):932-42.
  • Cerhan JR, Moore SC, Jacobs EJ, Kitahara CM, Rosenberg PS, Adami HO, Ebbert JO, English DR, Gapstur SM, Giles GG, Horn-Ross PL, Park Y, Patel AV, Robien K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Hartge P, Bernstein L, Berrington de Gonzalez A.A pooled analysis of waist circumference and mortality in 650,000 adults.Mayo Clin. Proc. 2014 Mar;89(3):335-45.
  • Kalager M, Adami HO, Bretthauer M.Too much mammography.BMJ. 2014;348:g1403.
  • Veierød MB, Couto E, Lund E, Adami HO, Weiderpass E.Host characteristics, sun exposure, indoor tanning and risk of squamous cell carcinoma of the skin.Int J Cancer. 2013 Dec 6.
  • Möller E, Adami HO, Mucci LA, Lundholm C, Bellocco R, Johansson JE, Grönberg H, Bälter K.Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden.Cancer Causes Control. 2013 Dec;24(12):2143-55.
  • Lagiou P, Hsieh CC, Samoli E, Lagiou A, Xu B, Yu GP, Onoyama S, Chie L, Vatten LJ, Adami HO, Trichopoulos D, Williams MA.Associations of placental weight with maternal and cord blood hormones.Ann Epidemiol. 2013 Nov;23(11):669-73.
  • Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Zeleniuch-Jacquotte A, Lawrence C, Burdette L, Yuenger J, Hutchinson A, Jacobs KB, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Wang AH, Smedby KE, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Jones B, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Holly EA, Smith MT, Jackson RD, Tinker LF, Benavente Y, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Leis JF, Cunningham JM, Weinberg JB, Morrison VA, Caporaso NE, Norman AD, Linet MS, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Giles GG, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Offit K, Zelenetz A, Klein RJ, Spinelli JJ, Bertrand KA, Laden F, Giovannucci E, Kraft P, Kricker A, Turner J, Vajdic CM, Ennas MG, Ferri GM, Miligi L, Liang L, Sampson J, Crouch S, Park JH, North KE, Cox A, Snowden JA, Wright J, Carracedo A, Lopez-Otin C, Bea S, Salaverria I, Martin-Garcia D, Campo E, Fraumeni JF, de Sanjose S, Hjalgrim H, Cerhan JR, Chanock SJ, Rothman N, Slager SL.Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.Nat Genet. 2013 Aug;45(8):868-76.
  • Paulus JK, Santoyo-Vistrain R, Havelick D, Cohen A, Kalyesubula R, Ajayi IO, Mattsson JG, Adami HO, Dalal S.Global teaching and training initiatives for emerging cohort studies.J Epidemiol Glob Health. 2012 Sep;2(3):125-33.
  • Foo JN, Smedby KE, Akers NK, Berglund M, Irwan ID, Jia X, Li Y, Conde L, Darabi H, Bracci PM, Melbye M, Adami HO, Glimelius B, Khor CC, Hjalgrim H, Padyukov L, Humphreys K, Enblad G, Skibola CF, de Bakker PI, Liu J.Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk.Am J Hum Genet. 2013 Jul 11;93(1):167-72.
  • Wilson KM, Bälter K, Möller E, Adami HO, Andrén O, Andersson SO, Grönberg H, Mucci LA.Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study.Cancer Causes Control. 2013 Aug;24(8):1575-81.
  • Karlsson R, Andreassen KE, Kristiansen W, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Magnusson PK, Adami HO, Haugen TB, Grotmol T, Wiklund F.Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4.Hum Mol Genet. 2013 May 10.
  • Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami HO, Stampfer M, Steingrimsdottir L.Consumption of Fish Products across the Lifespan and Prostate Cancer Risk.PLoS ONE. 2013;8(4):e59799.
  • Bill-Axelson A, Garmo H, Holmberg L, Johansson JE, Adami HO, Steineck G, Johansson E, Rider JR.Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial.Eur Urol. 2013 Feb 26.
  • Edgren G, Lagiou P, Trichopoulos D, Adami HO.Screening, case finding or primary cancer prevention in the developing world?.Eur J Epidemiol. 2013 Feb 27.
  • Couto E, Sandin S, Löf M, Ursin G, Adami HO, Weiderpass E.Mediterranean dietary pattern and risk of breast cancer.PLoS ONE. 2013;8(2):e55374.
  • Sergentanis TN, Antoniadis AG, Gogas HJ, Antonopoulos CN, Adami HO, Ekbom A, Petridou ET.Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies.Eur J Cancer. 2013 Feb;49(3):642-57.
  • Holmberg L, Bill-Axelson A, Steineck G, Garmo H, Palmgren J, Johansson E, Adami HO, Johansson JE.Results from the Scandinavian Prostate Cancer Group Trial Number 4: a randomized controlled trial of radical prostatectomy versus watchful waiting.J Natl Cancer Inst Monogr. 2012 Dec;2012(45):230-3.
  • Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM.Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.Int J Cancer. 2013 Feb 1;132(3):625-34.
  • Kalager M, Tamimi RM, Bretthauer M, Adami HO.Prognosis in women with interval breast cancer: population based observational cohort study.BMJ. 2012;345:e7536.
  • Simard JF, Baecklund F, Chang ET, Baecklund E, Hjalgrim H, Adami HO, Glimelius B, Smedby KE.Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes.Int J Cancer. 2012 Nov 15.
  • Sundstrom K, Ploner A, Arnheim Dahlström L, Palmgren J, Dillner J, Adami HO, Ylitalo N, Sparen P.Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.Cancer Epidemiol Biomarkers Prev. 2012 Nov 15.
  • Sandberg ME, Alkner S, Hartman M, Eloranta S, Rydén L, Ploner A, Adami HO, Hall P, Czene K.Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer.Int J Cancer. 2012 Oct 4.
  • Popiolek M, Rider JR, Andrén O, Andersson SO, Holmberg L, Adami HO, Johansson JE.Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up.Eur Urol. 2012 Oct 13.
  • Ghiasvand R, Bahmanyar S, Zendehdel K, Tahmasebi S, Talei A, Adami HO, Cnattingius S.Postmenopausal breast cancer in Iran; risk factors and their population attributable fractions.BMC Cancer. 2012 Sep 19;12(1):414.
  • Epstein MM, Edgren G, Rider JR, Mucci LA, Adami HO.Temporal trends in cause of death among Swedish and US men with prostate cancer.Journal of the National Cancer Institute. 2012 Sep 5;104(17):1335-42.
  • Etzioni R, Mucci LA, Chen S, Johansson JE, Fall K, Adami HO.Increasing use of radical prostatectomy for non-lethal prostate cancer in Sweden.Clin Cancer Res. 2012 Aug 27.
  • Edgren G, Adami HO, Weiderpass Vainio E, Nyrén O.A global assessment of the oesophageal adenocarcinoma epidemic.Gut. 2012 Aug 23.
  • Boffetta P, Adami HO, Berry SC, Mandel JS.Atrazine and cancer: a review of the epidemiologic evidence.Eur J Cancer Prev. 2012 Aug 21.
  • Spyridopoulos TN, Dessypris N, Antoniadis AG, Gialamas S, Antonopoulos CN, Katsifoti K, Adami HO, Chrousos GP, Petridou ET, .Insulin resistance and risk of renal cell cancer: a case-control study.Hormones (Athens). 2012 Jul;11(3):308-15.
  • Vanderweele TJ, Adami HO, Tamimi RM.Mammographic density as a mediator for breast cancer risk: analytic approaches.Breast Cancer Res. 2012 Jul 26;14(4):317.
  • Vickers A, Bennette C, Steineck G, Adami HO, Johansson JE, Bill-Axelson A, Palmgren J, Garmo H, Holmberg L.Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial.Eur Urol. 2012 Aug;62(2):204-9.
  • Lagiou P, Sandin S, Lof M, Trichopoulos D, Adami HO, Weiderpass E.Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study.BMJ. 2012;344:e4026.
  • Yang L, Lof M, Veierød MB, Sandin S, Adami HO, Weiderpass E.Ultraviolet Exposure and Mortality among Women in Sweden.Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):683-90.
  • Andersson SO, Andrén O, Lyth J, Stark JR, Henriksson M, Adami HO, Carlsson P, Johansson JE.Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).Scand J Urol Nephrol. 2011 Apr;45(3):177-83.
  • Behrens G, Leitzmann MF, Sandin S, Löf M, Heid IM, Adami HO, Weiderpass E.The association between alcohol consumption and mortality: the Swedish women's lifestyle and health study.Eur J Epidemiol. 2011 Feb;26(2):81-90.
  • Löf M, Sandin S, Lagiou P, Trichopoulos D, Adami HO, Weiderpass E.Fruit and vegetable intake and risk of cancer in the Swedish women's lifestyle and health cohort.Cancer Causes Control. 2011 Feb;22(2):283-9.
  • Fang F, Fall K, Sparén P, Adami HO, Valdimarsdóttir HB, Lambe M, Valdimarsdóttir U.Risk of infection-related cancers after the loss of a child: a follow-up study in Sweden.Cancer Res. 2011 Jan 1;71(1):116-22.
  • Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, van den Berg A, Olver B, Lloyd A, Dobbins SE, Lightfoot T, van Leeuwen FE, Försti A, Diepstra A, Broeks A, Vijayakrishnan J, Shield L, Lake A, Montgomery D, Roman E, Engert A, von Strandmann EP, Reiners KS, Nolte IM, Smedby KE, Adami HO, Russell NS, Glimelius B, Hamilton-Dutoit S, de Bruin M, Ryder LP, Molin D, Sorensen KM, Chang ET, Taylor M, Cooke R, Hofstra R, Westers H, van Wezel T, van Eijk R, Ashworth A, Rostgaard K, Melbye M, Swerdlow AJ, Houlston RS.A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).Nat Genet. 2010 Dec;42(12):1126-30.
  • Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L, Yaghoutyfam N, Marquis CP, Stattin P, Pedersen NL, Adami HO, Grönberg H, Breit SN, Brown DA.Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality.Aging Cell. 2010 Dec;9(6):1057-64.
  • Cole P, Adami HO, Trichopoulos D, Mandel J.Formaldehyde and lymphohematopoietic cancers: a review of two recent studies.Regul. Toxicol. Pharmacol. 2010 Nov;58(2):161-6.
  • Sundström K, Eloranta S, Sparén P, Arnheim Dahlström L, Gunnell A, Lindgren A, Palmgren J, Ploner A, Sanjeevi CB, Melbye M, Dillner J, Adami HO, Ylitalo N.Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2469-78.
  • Cole P, Adami HO, Trichopoulos D, Mandel JS.Re: Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde.Journal of the National Cancer Institute. 2010 Oct 6;102(19):1518-9; author reply 1519-20.
  • Kalager M, Zelen M, Langmark F, Adami HO.Effect of screening mammography on breast-cancer mortality in Norway.N Engl J Med. 2010 Sep 23;363(13):1203-10.
  • Meyer MS, Mucci LA, Andersson SO, Andrén O, Johansson JE, Tretli S, Adami HO.Homogeneous prostate cancer mortality in the Nordic countries over four decades.Eur Urol. 2010 Sep;58(3):427-32.
  • Marincevic M, Cahill N, Gunnarsson R, Isaksson A, Mansouri M, Göransson H, Rasmusson M, Jansson M, Ryan F, Karlsson K, Adami HO, Davi F, Jurlander J, Juliusson G, Stamatopoulus K, Rosenquist R.High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with "stereotyped" IGHV3-21 and IGHV4-34 B cell receptors.Haematologica. 2010 Sep;95(9):1519-25.
  • Dahlström LA, Ylitalo N, Sundström K, Palmgren J, Ploner A, Eloranta S, Sanjeevi CB, Andersson S, Rohan T, Dillner J, Adami HO, Sparén P.Prospective study of human papillomavirus and risk of cervical adenocarcinoma.Int J Cancer. 2010 Oct 15;127(8):1923-30.
  • Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, Adami HO, Darabi H, Hjalgrim H, Low HQ, Humphreys K, Melbye M, Chang ET, Glimelius B, Cozen W, Davis S, Hartge P, Morton LM, Schenk M, Wang SS, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Becker N, Benavente Y, Boffetta P, Brennan P, Butterbach K, Cocco P, Foretova L, Maynadié M, de Sanjosé S, Staines A, Spinelli JJ, Achenbach SJ, Call TG, Camp NJ, Glenn M, Caporaso NE, Cerhan JR, Cunningham JM, Goldin LR, Hanson CA, Kay NE, Lanasa MC, Leis JF, Marti GE, Rabe KG, Rassenti LZ, Spector LG, Strom SS, Vachon CM, Weinberg JB, Holly EA, Chanock S, Smith MT, Bracci PM, Skibola CF.Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.Nat Genet. 2010 Aug;42(8):661-4.
  • Edgren G, Bagnardi V, Bellocco R, Hjalgrim H, Rostgaard K, Melbye M, Reilly M, Adami HO, Hall P, Nyrén O.Pattern of declining hemoglobin concentration before cancer diagnosis.Int J Cancer. 2010 Sep 1;127(6):1429-36.
  • Veierød MB, Smedby KE, Lund E, Adami HO, Weiderpass E.Pigmentary characteristics, UV radiation exposure, and risk of non-Hodgkin lymphoma: a prospective study among Scandinavian women.Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1569-76.
  • Tamimi RM, Lagiou P, Czene K, Liu J, Ekbom A, Hsieh CC, Adami HO, Trichopoulos D, Hall P.Birth weight, breast cancer susceptibility loci, and breast cancer risk.Cancer Causes Control. 2010 May;21(5):689-96.
  • Adami HO.The prostate cancer pseudo-epidemic.Acta Oncol. 2010 Apr;49(3):298-304.
  • Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF.HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6400-5.
  • Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, Hoshida Y, Perner S, Adami HO, Fall K, Mucci LA, Kantoff PW, Stampfer M, Andersson SO, Varenhorst E, Johansson JE, Gerstein MB, Golub TR, Rubin MA, Andren O.Molecular sampling of prostate cancer: a dilemma for predicting disease progression.BMC Med Genomics. 2010 Mar 16;3(1):8.
  • Fang F, Keating NL, Mucci LA, Adami HO, Stampfer MJ, Valdimarsdóttir U, Fall K.Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.Journal of the National Cancer Institute. 2010 Mar 3;102(5):307-14.
  • Vikström AC, Wilson KM, Paulsson B, Athanassiadis I, Grönberg H, Adami HO, Adolfsson J, Mucci LA, Bälter K, Törnqvist M.Alcohol influence on acrylamide to glycidamide metabolism assessed with hemoglobin-adducts and questionnaire data.Food Chem Toxicol. 2010 Mar;48(3):820-4.
  • Veierød MB, Adami HO, Lund E, Armstrong BK, Weiderpass E.Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi.Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):111-20.
  • Tamimi RM, Eriksson L, Lagiou P, Czene K, Ekbom A, Hsieh CC, Adami HO, Trichopoulos D, Hall P.Birth weight and mammographic density among postmenopausal women in Sweden.Int J Cancer. 2010 Feb 15;126(4):985-91.
  • Fall K, Fang F, Mucci LA, Ye W, Andrén O, Johansson JE, Andersson SO, Sparén P, Klein G, Stampfer M, Adami HO, Valdimarsdóttir U.Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study.PLoS Med. 2009 Dec;6(12):e1000197.
  • Boffetta P, Adami HO, Cole P, Trichopoulos D, Mandel JS.Epidemiologic studies of styrene and cancer: a review of the literature.J Occup Environ Med. 2009 Nov;51(11):1275-87. Review.
  • Brown DA, Lindmark F, Stattin P, Bälter K, Adami HO, Zheng SL, Xu J, Isaacs WB, Grönberg H, Breit SN, Wiklund FE.Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer.Clin Cancer Res. 2009 Nov 1;15(21):6658-64.
  • Kalager M, Haldorsen T, Bretthauer M, Hoff G, Thoresen SO, Adami HO.Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study.Breast Cancer Res. 2009;11(4):R44.
  • Stark JR, Mucci L, Rothman KJ, Adami HO.Screening for prostate cancer remains controversial.BMJ. 2009;339:b3601.
  • Kuper H, Yang L, Sandin S, Lof M, Adami HO, Weiderpass E.Prospective study of solar exposure, dietary vitamin D intake, and risk of breast cancer among middle-aged women.Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2558-61.
  • Adami HO.Epidemiology and the elusive Nobel Prize.Epidemiology. 2009 Sep;20(5):635-7.
  • Lindstrom S,Adami HO,Balter K,Xu J,Zheng SL,Sun J,Stattin P,Gronberg H,Wiklund F.Genetic variation in the upstream region of ERG and prostate cancer.Cancer Causes Control. 2009 Sep;20(7):1173-80.
  • Wiklund F, Tretli S, Choueiri TK, Signoretti S, Fall K, Adami HO.Risk of bilateral renal cell cancer.J Clin Oncol. 2009 Aug 10;27(23):3737-41.
  • Johansson M,McKay JD,Rinaldi S,Wiklund F,Adami HO,Gronberg H,Kaaks R,Stattin P.Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.Prostate. 2009 Sep 1;69(12):1281-91.
  • Wiklund FE,Adami HO,Zheng SL,Stattin P,Isaacs WB,Gronberg H,Xu J.Established prostate cancer susceptibility variants are not associated with disease outcome.Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1659-62.
  • Johansson M,McKay JD,Wiklund F,Rinaldi S,Hallmans G,Balter K,Adami HO,Gronberg H,Stattin P,Kaaks R.Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1644-50.
  • Mucci LA,Adami HO.The plight of the potato: is dietary acrylamide a risk factor for human cancer?.Journal of the National Cancer Institute. 2009 May 6;101(9):618-21.
  • Biggar RJ,Christiansen M,Rostgaard K,Smedby KE,Adami HO,Glimelius B,Hjalgrim H,Melbye M.Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma.Int J Cancer. 2009 Jun 1;124(11):2616-20.
  • Zheng SL,Sun J,Wiklund F,Gao Z,Stattin P,Purcell LD,Adami HO,Hsu FC,Zhu Y,Adolfsson J,Johansson JE,Turner AR,Adams TS,Liu W,Duggan D,Carpten JD,Chang BL,Isaacs WB,Xu J,Gronberg H.Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.Clin Cancer Res. 2009 Feb 1;15(3):1105-11.
  • Wilson KM,Balter K,Adami HO,Gronberg H,Vikstrom AC,Paulsson B,Tornqvist M,Mucci LA.Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study.Int J Cancer. 2009 May 15;124(10):2384-90.
  • Wiklund F,Zheng SL,Sun J,Adami HO,Lilja H,Hsu FC,Stattin P,Adolfsson J,Cramer SD,Duggan D,Carpten JD,Chang BL,Isaacs WB,Gronberg H,Xu J.Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.Prostate. 2009 Mar 1;69(4):419-27.
  • Cooper ML,Adami HO,Gronberg H,Wiklund F,Green FR,Rayman MP.Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.Cancer Res. 2008 Dec 15;68(24):10171-7.
  • Holmberg L,Adolfsson J,Mucci L,Garmo H,Adami HO,Moller H,Johansson JE,Stampfer M.Season of diagnosis and prognosis in breast and prostate cancer.Cancer Causes Control. 2009 Jul;20(5):663-70.
  • Lagiou P,Samoli E,Lagiou A,Georgila C,Zourna P,Barbouni A,Gkiokas G,Vassilarou D,Tsikkinis A,Sfikas C,Sekeris CE,Hsieh CC,Adami HO,Trichopoulos D.Diet and expression of estrogen alpha and progesterone receptors in the normal mammary gland.Cancer Causes Control. 2009 Jul;20(5):601-7.
  • Biggar RJ,Johansen JS,Smedby KE,Rostgaard K,Chang ET,Adami HO,Glimelius B,Molin D,Hamilton-Dutoit S,Melbye M,Hjalgrim H.Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma.Clin Cancer Res. 2008 Nov 1;14(21):6974-8.
  • Wiklund F,Lageros YT,Chang E,Balter K,Johansson JE,Adami HO,Gronberg H.Lifetime total physical activity and prostate cancer risk: a population-based case-control study in Sweden.Eur J Epidemiol. 2008;23(11):739-46.
  • Lindstrom S,Adami HO,Adolfsson J,Wiklund F.Y chromosome haplotypes and prostate cancer in Sweden.Clin Cancer Res. 2008 Oct 15;14(20):6712-6.
  • Cnattingius S,Eloranta S,Adami HO,Axelsson O,Dickman PW,Hsieh CC,Mucci LA,Trichopoulos D,Lambe M,Johansson AL.Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset.Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2344-9.
  • Sun J,Zheng SL,Wiklund F,Isaacs SD,Purcell LD,Gao Z,Hsu FC,Kim ST,Liu W,Zhu Y,Stattin P,Adami HO,Wiley KE,Dimitrov L,Sun J,Li T,Turner AR,Adams TS,Adolfsson J,Johansson JE,Lowey J,Trock BJ,Partin AW,Walsh PC,Trent JM,Duggan D,Carpten J,Chang BL,Gronberg H,Isaacs WB,Xu J.Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.Nat Genet. 2008 Oct;40(10):1153-5.
  • Bill-Axelson A,Holmberg L,Filen F,Ruutu M,Garmo H,Busch C,Nordling S,Haggman M,Andersson SO,Bratell S,Spangberg A,Palmgren J,Adami HO,Johansson JE.Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.Journal of the National Cancer Institute. 2008 Aug 20;100(16):1144-54.
  • Mucci LA,Pawitan Y,Demichelis F,Fall K,Stark JR,Adami HO,Andersson SO,Andren O,Eisenstein A,Holmberg L,Huang W,Kantoff PW,Kim R,Perner S,Stampfer MJ,Johansson JE,Rubin MA.Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1682-8.
  • Schollkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B, Chang ET, Roos G, Hansen M, Adami HO, Hjalgrim H.Borrelia infection and risk of non-Hodgkin lymphoma.Blood. 2008 Jun 15;111(12):5524-9.
  • Baik I,Lambe M,Liu Q,Chie L,Cnattingius S,Mucci LA,Riman T,Ekbom A,Adami HO,Hsieh CC.Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort.Cancer Causes Control. 2008 Dec;19(10):1131-7.
  • Setlur SR,Mertz KD,Hoshida Y,Demichelis F,Lupien M,Perner S,Sboner A,Pawitan Y,Andren O,Johnson LA,Tang J,Adami HO,Calza S,Chinnaiyan AM,Rhodes D,Tomlins S,Fall K,Mucci LA,Kantoff PW,Stampfer MJ,Andersson SO,Varenhorst E,Johansson JE,Brown M,Golub TR,Rubin MA.Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.Journal of the National Cancer Institute. 2008 Jun 4;100(11):815-25.
  • Hsu FC,Lindstrom S,Sun J,Wiklund F,Chen SH,Adami HO,Turner AR,Liu W,Balter K,Kim JW,Stattin P,Chang BL,Isaacs WB,Xu J,Gronberg H,Zheng SL.A multigenic approach to evaluating prostate cancer risk in a systematic replication study.Cancer Genet Cytogenet. 2008 Jun;183(2):94-8.
  • Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, Beeson WL, van den Brandt PA, Buring JE, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Lacey JV Jr, Leitzmann M, Lukanova A, Marshall JR, Miller AB, Patel AV, Rodriguez C, Rohan TE, Ross JA, Wolk A, Zhang SM, Smith-Warner SA.Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):902-12. Review.
  • Mink PJ, Adami HO, Trichopoulos D, Britton NL, Mandel JS.Pesticides and prostate cancer: a review of epidemiologic studies with specific agricultural exposure information.Eur J Cancer Prev. 2008 Apr;17(2):97-110. Review.
  • Schollkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Panum I, Vinner L, Chang ET, Glimelius B, Porwit A, Sundstrom C, Hansen M, Adami HO, Melbye M.Hepatitis C infection and risk of malignant lymphoma.Int J Cancer. 2008 Apr 15;122(8):1885-90.
  • Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorleifsson G, Zheng SL, Sun J, Chang BL, Elmore JB, Breyer JP, McReynolds KM, Bradley KM, Yaspan BL, Wiklund F, Stattin P, Lindstrom S, Adami HO, McDonnell SK, Schaid DJ, Cunningham JM, Wang L, Cerhan JR, St Sauver JL, Isaacs SD, Wiley KE, Partin AW, Walsh PC, Polo S, Ruiz-Echarri M, Navarrete S, Fuertes F, Saez B, Godino J, Weijerman PC, Swinkels DW, Aben KK, Witjes JA, Suarez BK, Helfand BT, Frigge ML, Kristjansson K, Ober C, Jonsson E, Einarsson GV, Xu J, Gronberg H, Smith JR, Thibodeau SN, Isaacs WB, Catalona WJ, Mayordomo JI, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.Nat Genet. 2008 Mar;40(3):281-3.
  • Olsson M, Lindstrom S, Haggkvist B, Adami HO, Balter K, Stattin P, Ask B, Rane A, Ekstrom L, Gronberg H.The UGT2B17 gene deletion is not associated with prostate cancer risk.Prostate. 2008 Apr 1;68(5):571-5.
  • Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrn O, Eisenstein AS, Holmberg L, Huang W, Kantoff PW, Perner S, Stampfer MJ, Johansson JE, Rubin MA.Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):249-51.
  • Troisi R, Lagiou P, Trichopoulos D, Xu B, Chie L, Stanczyk FZ, Potischman N, Adami HO, Hoover RN, Hsieh CC.Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):224-31.
  • Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Gronberg H.Cumulative association of five genetic variants with prostate cancer.N Engl J Med. 2008 Feb 28;358(9):910-9.
  • Ioannidis JP, Adami HO.Nested randomized trials in large cohorts and biobanks: studying the health effects of lifestyle factors.Epidemiology. 2008 Jan;19(1):75-82.
  • Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Balter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Gronberg H, Xu J, Carpten JD.Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.Journal of the National Cancer Institute. 2007 Dec 19;99(24):1836-44.
  • Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F.Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.Journal of the National Cancer Institute. 2007 Dec 19;99(24):1881-7.
  • Trichopoulos D, Adami HO, Ekbom A, Hsieh CC, Lagiou P.Early life events and conditions and breast cancer risk: from epidemiology to etiology.Int J Cancer. 2008 Feb 1;122(3):481-5. Review.
  • Czene K, Adami HO, Chang ET.Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma.Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2496-9.
  • Smedby KE, Hjalgrim H, Chang ET, Rostgaard K, Glimelius B, Adami HO, Melbye M.Childhood social environment and risk of non-Hodgkin lymphoma in adults.Cancer Res. 2007 Nov 15;67(22):11074-82.
  • Baik I, Lambe M, Liu Q, Cnattingius S, Mucci LA, Riman T, Ekbom A, Adami HO, Hsieh CC.Gender of offspring and maternal risk of invasive epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2314-20.
  • Luo J, Adami HO, Reilly M, Ekbom A, Nordenvall C, Ye W.Interpreting trends of pancreatic cancer incidence and mortality: a nation-wide study in Sweden (1960-2003).Cancer Causes Control. 2008 Feb;19(1):89-96.
  • Gram IT, Braaten T, Adami HO, Lund E, Weiderpass E.Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer.Int J Cancer. 2008 Feb 1;122(3):647-52.
  • Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH, Hallmans G, Balter K, Adami HO, Gronberg H, Stattin P, Kaaks R.Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels.J Clin Endocrinol Metab. 2007 Dec;92(12):4820-6.
  • Demichelis F, Fall K, Perner S, Andrn O, Schmidt F, Setlur SR, Hoshida Y, Mosquera JM, Pawitan Y, Lee C, Adami HO, Mucci LA, Kantoff PW, Andersson SO, Chinnaiyan AM, Johansson JE, Rubin MA.TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.Oncogene. 2007 Jul 5;26(31):4596-9.
  • Hartman M, Lindstrom L, Dickman PW, Adami HO, Hall P, Czene K.Is breast cancer prognosis inherited?.Breast Cancer Res. 2007 Jun 28;9(3):R39.
  • Lee JE, Hunter DJ, Spiegelman D, Adami HO, Bernstein L, van den Brandt PA, Buring JE, Cho E, English D, Folsom AR, Freudenheim JL, Gile GG, Giovannucci E, Horn-Ross PL, Leitzmann M, Marshall JR, Mannisto S, McCullough ML, Miller AB, Parker AS, Pietinen P, Rodriguez C, Rohan TE, Schatzkin A, Schouten LJ, Willett WC, Wolk A, Zhang SM, Smith-Warner SA.Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies.Int J Cancer. 2007 Nov 15;121(10):2246-53.
  • Fall K, Garmo H, Andrn O, Bill-Axelson A, Adolfsson J, Adami HO, Johansson JE, Holmberg L,.Prostate-specific antigen levels as a predictor of lethal prostate cancer.J Natl Cancer Inst. 2007 Apr 4;99(7):526-32.
  • Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D.The non-Hodgkin lymphomas: a review of the epidemiologic literature.Int J Cancer. 2007;120 Suppl 12:1-39. Review.
  • Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D.Multiple myeloma: a review of the epidemiologic literature.Int J Cancer. 2007;120 Suppl 12:40-61. Review.
  • Melbye M, Smedby KE, Lehtinen T, Rostgaard K, Glimelius B, Munksgaard L, Schllkopf C, Sundstrm C, Chang ET, Koskela P, Adami HO, Hjalgrim H.Atopy and risk of non-Hodgkin lymphoma.J Natl Cancer Inst. 2007 Jan 17;99(2):158-66.
  • McKay JD, Kaaks R, Johansson M, Biessy C, Wiklund F, Blter K, Adami HO, Boillot C, Gioia-Patricola L, Canzian F, Stattin P, Grnberg H.Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):169-73.
  • Johansson M, McKay JD, Stattin P, Canzian F, Boillot C, Wiklund F, Adami HO, Blter K, Grnberg H, Kaaks R.Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.Int J Cancer. 2007 Feb 1;120(3):539-42.